[contentcards url=”https://www.forbes.com/sites/ralphjennings/2021/03/17/south-koreas-sk-group-makes-biotech-push-with-13-billion-ipo-of-covid-vaccine-unit/?sh=461813fd23df”] By Ralph Jennings SK Group, one of South Korea’s massive, family-controlled businesses known as chaebol, is expected to list its vaccine making unit,…